Watch Ticker

Corcept Therapeutics Inc.

Go to Corcept Therapeutics Inc. Website

$70.45

-1.32 (-1.84%)

Live

Previous Close

$70.45

Day Range

$70.03 - $71.7899

Previous Day Range

$66.46 - $71.91

Market Cap

$7.6 billion USD

Day Vol.

746491

Previous Day Vol.

1.8 million

Currency

USD

Primary Exchange

Nasdaq

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - High- and Low-Grade Serous Ovarian Cancer Market is Predicted to Grow at a CAGR of 7.9% During the Study Period (2020–2034) | DelveInsight

The global high- and low-grade serous ovarian cancer market is expected to grow at a CAGR of 7.9% from 2020 to 2034, driven by the launch of emerging therapies. The US market is the largest, capturing nearly USD 1.9 billion in 2024. Key companies working on innovative ovarian cancer drugs include Verastem Oncology, Corcept Therapeutics, AstraZeneca, and others.

Related tickers: CORT, AZN.

Read Full Article

Delveinsight - Alcohol Use Disorder Market Set for Remarkable Growth During the Study Period (2020–2034) | DelveInsight

The alcohol use disorder market is expected to show positive growth, with growing awareness about AUD and reduced stigma surrounding mental health issues encouraging more individuals to seek treatment during the forecast period (2024–2034).

Related tickers: ADIL, CORT, CMND.

Read Full Article

Trending Tickers

Please sign in to view